XNAS · CNSP
-4.67% · -$0.2800 · Vol 8.1K
Market closed · last close 4:00 PM ET · price as of 18:24:21 ET
CNS Pharmaceuticals, Inc. Common Stock

CNS Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$5.72
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
CNSP
CNS Pharmaceuticals, Inc. Common Stock
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

56/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CNSP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CNSP catalysts
About CNS Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
8
Country
US

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.96
Day high
$6.05
Day low
$5.83
Previous close
$6.00
52W high
$10.57
-45.88% from high
52W low
$2.13
43% of range
Market cap
$8.5M
EPS
$-19.8600
Beta
-1.05
Shares out
1.5M
Volume
8.1K
1.04× rel vol
Avg volume
7.8K
VWAP
$5.94
Price history computed in-house
1W
+5.93%
1M
+9.37%
3M
+9.58%
1Y
-11.73%
YTD
+8.95%
SMA 50 $5.07 · above
SMA 200 $4.88 · above
52W position 43%

CNSP overview

Veridion Score
56
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CNSP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CNSP Form 4 filings
Public disclosures

Congress activity in CNSP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CNSP in the cached public ledger.

Federal contracts

CNSP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNSP in this window.
Lobbying spend

CNSP lobbying filings, year to date.

Registered lobbying filings matched to CNS Pharmaceuticals, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNSP in this window.
Loading news for CNSP
Analyst ratings
Sovereign unlock shows live analyst consensus for CNSP.
Options
Sovereign unlock shows live options positioning for CNSP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.